nodes	percent_of_prediction	percent_of_DWPC	metapath
Marimastat—MMP13—synovial fluid—psoriasis	0.0529	0.0863	CbGeAlD
Marimastat—MMP3—synovial fluid—psoriasis	0.0491	0.08	CbGeAlD
Marimastat—MMP1—synovial fluid—psoriasis	0.0372	0.0607	CbGeAlD
Marimastat—MMP3—dermis—psoriasis	0.0368	0.06	CbGeAlD
Marimastat—MMP13—skeletal joint—psoriasis	0.0342	0.0558	CbGeAlD
Marimastat—MMP3—skeletal joint—psoriasis	0.0317	0.0518	CbGeAlD
Marimastat—MMP1—dermis—psoriasis	0.0279	0.0455	CbGeAlD
Marimastat—MMP13—synovial membrane of synovial joint—psoriasis	0.026	0.0424	CbGeAlD
Marimastat—MMP3—vertebral column—psoriasis	0.0252	0.0412	CbGeAlD
Marimastat—MMP9—synovial fluid—psoriasis	0.0249	0.0406	CbGeAlD
Marimastat—MMP3—synovial membrane of synovial joint—psoriasis	0.0241	0.0393	CbGeAlD
Marimastat—MMP1—skeletal joint—psoriasis	0.0241	0.0393	CbGeAlD
Marimastat—MMP2—dermis—psoriasis	0.0214	0.035	CbGeAlD
Marimastat—MMP9—dermis—psoriasis	0.0186	0.0304	CbGeAlD
Marimastat—MMP2—skeletal joint—psoriasis	0.0185	0.0302	CbGeAlD
Marimastat—MMP1—synovial membrane of synovial joint—psoriasis	0.0183	0.0298	CbGeAlD
Marimastat—MMP9—skeletal joint—psoriasis	0.0161	0.0263	CbGeAlD
Marimastat—MMP1—skin epidermis—psoriasis	0.0117	0.0191	CbGeAlD
Marimastat—MMP14—endothelium—psoriasis	0.0107	0.0175	CbGeAlD
Marimastat—MMP21—tendon—psoriasis	0.0104	0.0169	CbGeAlD
Marimastat—MMP2—skin epidermis—psoriasis	0.00902	0.0147	CbGeAlD
Marimastat—MMP28—skin of body—psoriasis	0.00879	0.0143	CbGeAlD
Marimastat—MMP1—endothelium—psoriasis	0.00851	0.0139	CbGeAlD
Marimastat—MMP9—skin epidermis—psoriasis	0.00784	0.0128	CbGeAlD
Marimastat—MMP10—skin of body—psoriasis	0.00666	0.0109	CbGeAlD
Marimastat—MMP2—endothelium—psoriasis	0.00654	0.0107	CbGeAlD
Marimastat—MMP9—endothelium—psoriasis	0.00569	0.00929	CbGeAlD
Marimastat—MMP3—skin of body—psoriasis	0.00479	0.00782	CbGeAlD
Marimastat—MMP14—skin of body—psoriasis	0.00458	0.00747	CbGeAlD
Marimastat—MMP19—tendon—psoriasis	0.00403	0.00657	CbGeAlD
Marimastat—MMP13—tendon—psoriasis	0.00393	0.00642	CbGeAlD
Marimastat—MMP3—tendon—psoriasis	0.00365	0.00595	CbGeAlD
Marimastat—MMP1—skin of body—psoriasis	0.00363	0.00593	CbGeAlD
Marimastat—MMP14—tendon—psoriasis	0.00348	0.00568	CbGeAlD
Marimastat—MMP2—skin of body—psoriasis	0.00279	0.00456	CbGeAlD
Marimastat—MMP1—tendon—psoriasis	0.00276	0.00451	CbGeAlD
Marimastat—MMP9—skin of body—psoriasis	0.00243	0.00396	CbGeAlD
Marimastat—MMP2—tendon—psoriasis	0.00213	0.00347	CbGeAlD
Marimastat—MMP9—tendon—psoriasis	0.00185	0.00302	CbGeAlD
Marimastat—MMP2—Betamethasone—Clobetasol propionate—psoriasis	0.00138	0.0968	CbGdCrCtD
Marimastat—MMP2—Dexamethasone—Clobetasol propionate—psoriasis	0.00138	0.0968	CbGdCrCtD
Marimastat—MMP2—Betamethasone—Beclomethasone—psoriasis	0.0011	0.0775	CbGdCrCtD
Marimastat—MMP2—Dexamethasone—Fluocinonide—psoriasis	0.0011	0.0775	CbGdCrCtD
Marimastat—MMP2—Dexamethasone—Beclomethasone—psoriasis	0.0011	0.0775	CbGdCrCtD
Marimastat—MMP2—Betamethasone—Fluocinonide—psoriasis	0.0011	0.0775	CbGdCrCtD
Marimastat—MMP2—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00107	0.0753	CbGdCrCtD
Marimastat—MMP2—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00107	0.0753	CbGdCrCtD
Marimastat—MMP7—AGE/RAGE pathway—NFKB1—psoriasis	0.000971	0.0026	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—IL10—psoriasis	0.000958	0.00257	CbGpPWpGaD
Marimastat—MMP15—Extracellular matrix organization—ICAM1—psoriasis	0.000948	0.00254	CbGpPWpGaD
Marimastat—MMP11—Extracellular matrix organization—ICAM1—psoriasis	0.000948	0.00254	CbGpPWpGaD
Marimastat—MMP10—Extracellular matrix organization—ICAM1—psoriasis	0.000948	0.00254	CbGpPWpGaD
Marimastat—MMP2—Extracellular matrix organization—ITGAL—psoriasis	0.000943	0.00253	CbGpPWpGaD
Marimastat—MMP13—Endochondral Ossification—VEGFA—psoriasis	0.000935	0.00251	CbGpPWpGaD
Marimastat—MMP2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000935	0.00251	CbGpPWpGaD
Marimastat—MMP9—Osteopontin-mediated events—JUN—psoriasis	0.000934	0.0025	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—IL4—psoriasis	0.000931	0.0025	CbGpPWpGaD
Marimastat—MMP13—Oncostatin M Signaling Pathway—VEGFA—psoriasis	0.000924	0.00248	CbGpPWpGaD
Marimastat—MMP2—ATF-2 transcription factor network—CXCL8—psoriasis	0.000915	0.00245	CbGpPWpGaD
Marimastat—MMP13—Oncostatin M Signaling Pathway—STAT3—psoriasis	0.000915	0.00245	CbGpPWpGaD
Marimastat—MMP12—Spinal Cord Injury—IFNG—psoriasis	0.00091	0.00244	CbGpPWpGaD
Marimastat—MMP13—AGE/RAGE pathway—STAT3—psoriasis	0.000904	0.00242	CbGpPWpGaD
Marimastat—MMP9—Osteopontin-mediated events—NFKB1—psoriasis	0.000899	0.00241	CbGpPWpGaD
Marimastat—MMP1—AP-1 transcription factor network—IFNG—psoriasis	0.00089	0.00239	CbGpPWpGaD
Marimastat—MMP20—Extracellular matrix organization—ICAM1—psoriasis	0.000881	0.00236	CbGpPWpGaD
Marimastat—MMP9—amb2 Integrin signaling—NFKB1—psoriasis	0.000876	0.00235	CbGpPWpGaD
Marimastat—MMP7—AGE/RAGE pathway—STAT3—psoriasis	0.000873	0.00234	CbGpPWpGaD
Marimastat—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—psoriasis	0.000872	0.00234	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—VDR—psoriasis	0.000862	0.00231	CbGpPWpGaD
Marimastat—MMP2—LPA receptor mediated events—CXCL8—psoriasis	0.000857	0.0023	CbGpPWpGaD
Marimastat—MMP2—ATF-2 transcription factor network—JUN—psoriasis	0.000851	0.00228	CbGpPWpGaD
Marimastat—MMP12—Spinal Cord Injury—CXCL8—psoriasis	0.000846	0.00227	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—HLA-A—psoriasis	0.000844	0.00226	CbGpPWpGaD
Marimastat—MMP2—amb2 Integrin signaling—IL6—psoriasis	0.000839	0.00225	CbGpPWpGaD
Marimastat—MMP1—Endothelins—JUN—psoriasis	0.000837	0.00225	CbGpPWpGaD
Marimastat—MMP1—AP-1 transcription factor network—CXCL8—psoriasis	0.000828	0.00222	CbGpPWpGaD
Marimastat—MMP3—Oncostatin M Signaling Pathway—TP53—psoriasis	0.000814	0.00218	CbGpPWpGaD
Marimastat—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—psoriasis	0.000811	0.00217	CbGpPWpGaD
Marimastat—MMP2—LPA receptor mediated events—JUN—psoriasis	0.000797	0.00214	CbGpPWpGaD
Marimastat—MMP9—LPA receptor mediated events—NFKBIA—psoriasis	0.000789	0.00212	CbGpPWpGaD
Marimastat—MMP1—Oncostatin M Signaling Pathway—NFKB1—psoriasis	0.000786	0.00211	CbGpPWpGaD
Marimastat—MMP14—Extracellular matrix organization—ICAM1—psoriasis	0.000785	0.00211	CbGpPWpGaD
Marimastat—MMP1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	0.000784	0.0021	CbGpPWpGaD
Marimastat—MMP2—AGE/RAGE pathway—JUN—psoriasis	0.000778	0.00209	CbGpPWpGaD
Marimastat—MMP3—p75(NTR)-mediated signaling—TP53—psoriasis	0.000776	0.00208	CbGpPWpGaD
Marimastat—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—psoriasis	0.000774	0.00208	CbGpPWpGaD
Marimastat—MMP9—AGE/RAGE pathway—NOS2—psoriasis	0.00077	0.00206	CbGpPWpGaD
Marimastat—MMP9—AGE/RAGE pathway—NFKBIA—psoriasis	0.00077	0.00206	CbGpPWpGaD
Marimastat—MMP1—AP-1 transcription factor network—JUN—psoriasis	0.000769	0.00206	CbGpPWpGaD
Marimastat—MMP2—LPA receptor mediated events—NFKB1—psoriasis	0.000767	0.00206	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—PCNA—psoriasis	0.000765	0.00205	CbGpPWpGaD
Marimastat—ADAM10—Copper homeostasis—TP53—psoriasis	0.000758	0.00203	CbGpPWpGaD
Marimastat—MMP2—AGE/RAGE pathway—NFKB1—psoriasis	0.000749	0.00201	CbGpPWpGaD
Marimastat—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—psoriasis	0.000747	0.002	CbGpPWpGaD
Marimastat—MMP1—Integrated Cancer Pathway—TP53—psoriasis	0.000736	0.00198	CbGpPWpGaD
Marimastat—MMP9—TWEAK Signaling Pathway—JUN—psoriasis	0.000732	0.00196	CbGpPWpGaD
Marimastat—MMP1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	0.000729	0.00196	CbGpPWpGaD
Marimastat—MMP2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.000727	0.00195	CbGpPWpGaD
Marimastat—MMP12—TGF-beta Signaling Pathway—JUN—psoriasis	0.000719	0.00193	CbGpPWpGaD
Marimastat—MMP8—Extracellular matrix organization—ICAM1—psoriasis	0.000718	0.00193	CbGpPWpGaD
Marimastat—MMP9—Matrix Metalloproteinases—TNF—psoriasis	0.000718	0.00193	CbGpPWpGaD
Marimastat—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	0.000717	0.00192	CbGpPWpGaD
Marimastat—MMP1—Oncostatin M Signaling Pathway—VEGFA—psoriasis	0.000713	0.00191	CbGpPWpGaD
Marimastat—MMP14—Senescence and Autophagy in Cancer—TP53—psoriasis	0.000713	0.00191	CbGpPWpGaD
Marimastat—MMP7—Wnt Signaling Pathway and Pluripotency—JUN—psoriasis	0.000712	0.00191	CbGpPWpGaD
Marimastat—MMP1—Oncostatin M Signaling Pathway—STAT3—psoriasis	0.000706	0.00189	CbGpPWpGaD
Marimastat—MMP9—TWEAK Signaling Pathway—NFKB1—psoriasis	0.000705	0.00189	CbGpPWpGaD
Marimastat—MMP13—Oncostatin M Signaling Pathway—TP53—psoriasis	0.000698	0.00187	CbGpPWpGaD
Marimastat—MMP9—amb2 Integrin signaling—TNF—psoriasis	0.000682	0.00183	CbGpPWpGaD
Marimastat—MMP1—Glucocorticoid receptor regulatory network—JUN—psoriasis	0.000678	0.00182	CbGpPWpGaD
Marimastat—MMP2—AGE/RAGE pathway—STAT3—psoriasis	0.000673	0.0018	CbGpPWpGaD
Marimastat—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	0.000667	0.00179	CbGpPWpGaD
Marimastat—MMP9—CXCR4-mediated signaling events—HLA-DRB1—psoriasis	0.000666	0.00179	CbGpPWpGaD
Marimastat—MMP1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	0.000653	0.00175	CbGpPWpGaD
Marimastat—MMP14—Senescence and Autophagy in Cancer—IL6—psoriasis	0.000653	0.00175	CbGpPWpGaD
Marimastat—MMP7—p75(NTR)-mediated signaling—TP53—psoriasis	0.000643	0.00172	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—CARM1—psoriasis	0.000642	0.00172	CbGpPWpGaD
Marimastat—ADAM10—Signaling by NOTCH—JUN—psoriasis	0.000635	0.0017	CbGpPWpGaD
Marimastat—MMP12—Extracellular matrix organization—ICAM1—psoriasis	0.000628	0.00168	CbGpPWpGaD
Marimastat—ADAM10—EPH-Ephrin signaling—VEGFA—psoriasis	0.000625	0.00168	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—HCAR2—psoriasis	0.000621	0.00166	CbGpPWpGaD
Marimastat—MMP9—Extracellular matrix organization—ITGAL—psoriasis	0.000619	0.00166	CbGpPWpGaD
Marimastat—ADAM10—Alzheimers Disease—TNF—psoriasis	0.000615	0.00165	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—IL4—psoriasis	0.000613	0.00165	CbGpPWpGaD
Marimastat—MMP3—Extracellular matrix organization—ICAM1—psoriasis	0.000611	0.00164	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—SOCS1—psoriasis	0.00061	0.00164	CbGpPWpGaD
Marimastat—MMP9—FGF signaling pathway—JUN—psoriasis	0.000599	0.00161	CbGpPWpGaD
Marimastat—MMP12—Spinal Cord Injury—TNF—psoriasis	0.000589	0.00158	CbGpPWpGaD
Marimastat—MMP3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000585	0.00157	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—ITGAL—psoriasis	0.000581	0.00156	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—IFNG—psoriasis	0.000563	0.00151	CbGpPWpGaD
Marimastat—MMP9—LPA receptor mediated events—CXCL8—psoriasis	0.000562	0.00151	CbGpPWpGaD
Marimastat—MMP9—amb2 Integrin signaling—IL6—psoriasis	0.00055	0.00148	CbGpPWpGaD
Marimastat—MMP9—TWEAK Signaling Pathway—TNF—psoriasis	0.000548	0.00147	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—CCL20—psoriasis	0.000546	0.00146	CbGpPWpGaD
Marimastat—MMP2—Dexamethasone—Hydrocortisone—psoriasis	0.000542	0.0381	CbGdCrCtD
Marimastat—MMP2—Betamethasone—Hydrocortisone—psoriasis	0.000542	0.0381	CbGdCrCtD
Marimastat—ADAM10—Alzheimers Disease—TP53—psoriasis	0.000542	0.00145	CbGpPWpGaD
Marimastat—MMP1—Oncostatin M Signaling Pathway—TP53—psoriasis	0.000539	0.00145	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—TAGAP—psoriasis	0.000538	0.00144	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR—TYK2—psoriasis	0.000528	0.00141	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—CARM1—psoriasis	0.000526	0.00141	CbGpPWpGaD
Marimastat—MMP13—Extracellular matrix organization—ICAM1—psoriasis	0.000524	0.00141	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—CXCL8—psoriasis	0.000524	0.0014	CbGpPWpGaD
Marimastat—MMP9—LPA receptor mediated events—JUN—psoriasis	0.000523	0.0014	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—TYK2—psoriasis	0.000523	0.0014	CbGpPWpGaD
Marimastat—MMP1—Metabolism of proteins—REN—psoriasis	0.000519	0.00139	CbGpPWpGaD
Marimastat—MMP12—Spinal Cord Injury—TP53—psoriasis	0.000519	0.00139	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—LEP—psoriasis	0.000519	0.00139	CbGpPWpGaD
Marimastat—MMP9—FGF signaling pathway—STAT3—psoriasis	0.000518	0.00139	CbGpPWpGaD
Marimastat—MMP2—ATF-2 transcription factor network—IL6—psoriasis	0.000514	0.00138	CbGpPWpGaD
Marimastat—MMP2—EPH-Ephrin signaling—VEGFA—psoriasis	0.000512	0.00137	CbGpPWpGaD
Marimastat—MMP9—AGE/RAGE pathway—JUN—psoriasis	0.00051	0.00137	CbGpPWpGaD
Marimastat—MMP1—AP-1 transcription factor network—TP53—psoriasis	0.000508	0.00136	CbGpPWpGaD
Marimastat—MMP7—Extracellular matrix organization—ICAM1—psoriasis	0.000506	0.00136	CbGpPWpGaD
Marimastat—MMP2—Dexamethasone—Betamethasone—psoriasis	0.000504	0.0353	CbGdCrCtD
Marimastat—MMP2—Betamethasone—Dexamethasone—psoriasis	0.000504	0.0353	CbGdCrCtD
Marimastat—MMP9—LPA receptor mediated events—NFKB1—psoriasis	0.000503	0.00135	CbGpPWpGaD
Marimastat—MMP2—Metabolism of proteins—REN—psoriasis	0.000501	0.00134	CbGpPWpGaD
Marimastat—MMP2—Dexamethasone—Triamcinolone—psoriasis	0.000492	0.0345	CbGdCrCtD
Marimastat—MMP2—Betamethasone—Triamcinolone—psoriasis	0.000492	0.0345	CbGdCrCtD
Marimastat—MMP9—AGE/RAGE pathway—NFKB1—psoriasis	0.000491	0.00132	CbGpPWpGaD
Marimastat—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—psoriasis	0.00049	0.00131	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—ICAM1—psoriasis	0.000487	0.00131	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—JUN—psoriasis	0.000487	0.00131	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—HCAR2—psoriasis	0.000483	0.0013	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—NOS2—psoriasis	0.000483	0.0013	CbGpPWpGaD
Marimastat—ADAM10—Extracellular matrix organization—ICAM1—psoriasis	0.000476	0.00128	CbGpPWpGaD
Marimastat—MMP12—Spinal Cord Injury—IL6—psoriasis	0.000475	0.00127	CbGpPWpGaD
Marimastat—MMP12—TGF-beta Signaling Pathway—TP53—psoriasis	0.000475	0.00127	CbGpPWpGaD
Marimastat—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	0.00047	0.00126	CbGpPWpGaD
Marimastat—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—psoriasis	0.00047	0.00126	CbGpPWpGaD
Marimastat—MMP9—CXCR4-mediated signaling events—CD4—psoriasis	0.00047	0.00126	CbGpPWpGaD
Marimastat—MMP2—Betamethasone—Prednisone—psoriasis	0.000467	0.0328	CbGdCrCtD
Marimastat—MMP2—Dexamethasone—Prednisone—psoriasis	0.000467	0.0328	CbGdCrCtD
Marimastat—MMP1—AP-1 transcription factor network—IL6—psoriasis	0.000465	0.00125	CbGpPWpGaD
Marimastat—MMP1—TGF-beta Signaling Pathway—JUN—psoriasis	0.000463	0.00124	CbGpPWpGaD
Marimastat—MMP9—Endochondral Ossification—VEGFA—psoriasis	0.000457	0.00123	CbGpPWpGaD
Marimastat—MMP2—Betamethasone—Prednisolone—psoriasis	0.000456	0.032	CbGdCrCtD
Marimastat—MMP2—Dexamethasone—Prednisolone—psoriasis	0.000456	0.032	CbGdCrCtD
Marimastat—MMP1—Glucocorticoid receptor regulatory network—TP53—psoriasis	0.000448	0.0012	CbGpPWpGaD
Marimastat—MMP9—TWEAK Signaling Pathway—IL6—psoriasis	0.000443	0.00119	CbGpPWpGaD
Marimastat—MMP9—AGE/RAGE pathway—STAT3—psoriasis	0.000441	0.00118	CbGpPWpGaD
Marimastat—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	0.000437	0.00117	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—JUN—psoriasis	0.000426	0.00114	CbGpPWpGaD
Marimastat—ADAM10—Signaling by NOTCH—TP53—psoriasis	0.000419	0.00112	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—TAGAP—psoriasis	0.000419	0.00112	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—JUN—psoriasis	0.000416	0.00112	CbGpPWpGaD
Marimastat—MMP1—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.00041	0.0011	CbGpPWpGaD
Marimastat—MMP1—Extracellular matrix organization—ICAM1—psoriasis	0.000405	0.00108	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	0.0004	0.00107	CbGpPWpGaD
Marimastat—MMP2—Extracellular matrix organization—ICAM1—psoriasis	0.00039	0.00105	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—IFNG—psoriasis	0.000371	0.000995	CbGpPWpGaD
Marimastat—MMP9—CXCR4-mediated signaling events—STAT3—psoriasis	0.000364	0.000976	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	0.000363	0.000975	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—CARM1—psoriasis	0.000345	0.000926	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—CXCL8—psoriasis	0.000345	0.000925	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—TYK2—psoriasis	0.000343	0.000921	CbGpPWpGaD
Marimastat—MMP9—EPH-Ephrin signaling—VEGFA—psoriasis	0.000336	0.000901	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—TYK2—psoriasis	0.000328	0.00088	CbGpPWpGaD
Marimastat—MMP1—Metabolism of proteins—ACE—psoriasis	0.000324	0.000869	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—CCL20—psoriasis	0.000322	0.000865	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—TP53—psoriasis	0.000321	0.000862	CbGpPWpGaD
Marimastat—MMP2—Metabolism of proteins—ACE—psoriasis	0.000313	0.000838	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—LEP—psoriasis	0.000307	0.000823	CbGpPWpGaD
Marimastat—MMP1—TGF-beta Signaling Pathway—TP53—psoriasis	0.000306	0.00082	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—IL6—psoriasis	0.000294	0.000789	CbGpPWpGaD
Marimastat—MMP9—Validated targets of C-MYC transcriptional activation—TP53—psoriasis	0.000292	0.000782	CbGpPWpGaD
Marimastat—MMP3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000286	0.000767	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—TP53—psoriasis	0.000281	0.000755	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—TP53—psoriasis	0.000275	0.000737	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—TYK2—psoriasis	0.000269	0.000722	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—PPARG—psoriasis	0.000267	0.000717	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—HCAR2—psoriasis	0.00026	0.000697	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR—IL6—psoriasis	0.000258	0.000692	CbGpPWpGaD
Marimastat—MMP9—Extracellular matrix organization—ICAM1—psoriasis	0.000256	0.000686	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—IL6—psoriasis	0.000256	0.000686	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—LEP—psoriasis	0.000252	0.000675	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—CCL20—psoriasis	0.000251	0.000674	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—STAT3—psoriasis	0.00024	0.000645	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—TNF—psoriasis	0.00024	0.000644	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—NOS2—psoriasis	0.000238	0.00064	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—TYK2—psoriasis	0.000234	0.000628	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—VEGFA—psoriasis	0.000232	0.000622	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—TAGAP—psoriasis	0.000225	0.000605	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—PPARG—psoriasis	0.000219	0.000588	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—TP53—psoriasis	0.000212	0.000567	CbGpPWpGaD
Marimastat—MMP1—Metabolism of proteins—LEP—psoriasis	0.000201	0.00054	CbGpPWpGaD
Marimastat—MMP2—Metabolism of proteins—LEP—psoriasis	0.000194	0.000521	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—IL6—psoriasis	0.000194	0.000519	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—TYK2—psoriasis	0.000192	0.000515	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—VEGFA—psoriasis	0.00019	0.00051	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—NFKB1—psoriasis	0.000182	0.000489	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—SOCS1—psoriasis	0.000177	0.000476	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—TYK2—psoriasis	0.000176	0.000473	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—TYK2—psoriasis	0.000169	0.000454	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—IL6—psoriasis	0.000168	0.00045	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—VEGFA—psoriasis	0.000166	0.000444	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—LEP—psoriasis	0.000165	0.000443	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—STAT3—psoriasis	0.000164	0.00044	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—IL6—psoriasis	0.000161	0.000431	CbGpPWpGaD
Marimastat—ADAM10—Disease—HLA-A—psoriasis	0.000156	0.000419	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—NFKB1—psoriasis	0.00015	0.000401	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—CXCL8—psoriasis	0.000147	0.000395	CbGpPWpGaD
Marimastat—ADAM10—Disease—APOE—psoriasis	0.000146	0.000391	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—PPARG—psoriasis	0.000144	0.000386	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—TNF—psoriasis	0.000142	0.000381	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—SOCS1—psoriasis	0.000138	0.000371	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—VEGFA—psoriasis	0.000138	0.00037	CbGpPWpGaD
Marimastat—ADAM10—Disease—NOS2—psoriasis	0.000136	0.000364	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—VEGFA—psoriasis	0.000136	0.000364	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—CCL20—psoriasis	0.000135	0.000362	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—STAT3—psoriasis	0.000134	0.000361	CbGpPWpGaD
Marimastat—MMP1—Metabolism of proteins—CXCL8—psoriasis	0.000134	0.000359	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—IL6—psoriasis	0.000132	0.000353	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—APOE—psoriasis	0.000131	0.000351	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—LEP—psoriasis	0.000131	0.000351	CbGpPWpGaD
Marimastat—MMP2—Metabolism of proteins—CXCL8—psoriasis	0.000129	0.000346	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—TYK2—psoriasis	0.000126	0.000338	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—VEGFA—psoriasis	0.000125	0.000335	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—NFKBIA—psoriasis	0.000122	0.000327	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—TNF—psoriasis	0.000116	0.000312	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—IL6—psoriasis	0.000115	0.000307	CbGpPWpGaD
Marimastat—ADAM10—Disease—TYK2—psoriasis	0.000111	0.000298	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—TP53—psoriasis	0.000104	0.00028	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—LEP—psoriasis	0.000102	0.000274	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—APOE—psoriasis	0.000102	0.000274	CbGpPWpGaD
Marimastat—ADAM10—Disease—CD4—psoriasis	0.000101	0.00027	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—TYK2—psoriasis	0.0001	0.000268	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—NFKB1—psoriasis	9.81e-05	0.000263	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—NFKBIA—psoriasis	9.51e-05	0.000255	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—IL6—psoriasis	9.39e-05	0.000252	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—VEGFA—psoriasis	8.91e-05	0.000239	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—STAT3—psoriasis	8.82e-05	0.000237	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—CXCL8—psoriasis	8.7e-05	0.000233	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—IL6—psoriasis	8.63e-05	0.000232	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—IL6—psoriasis	8.28e-05	0.000222	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—JUN—psoriasis	8.09e-05	0.000217	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—NFKB1—psoriasis	7.79e-05	0.000209	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—TYK2—psoriasis	7.79e-05	0.000209	CbGpPWpGaD
Marimastat—ADAM10—Disease—STAT3—psoriasis	7.79e-05	0.000209	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—TNF—psoriasis	7.63e-05	0.000205	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—SOCS1—psoriasis	7.44e-05	0.000199	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—VEGFA—psoriasis	7.07e-05	0.00019	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—STAT3—psoriasis	7e-05	0.000188	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—CXCL8—psoriasis	6.78e-05	0.000182	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—JUN—psoriasis	6.3e-05	0.000169	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—IL6—psoriasis	6.16e-05	0.000165	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—NFKB1—psoriasis	6.07e-05	0.000163	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—VEGFA—psoriasis	5.51e-05	0.000148	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—LEP—psoriasis	5.49e-05	0.000147	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—APOE—psoriasis	5.49e-05	0.000147	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—STAT3—psoriasis	5.45e-05	0.000146	CbGpPWpGaD
Marimastat—ADAM10—Disease—IL6—psoriasis	5.44e-05	0.000146	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—TP53—psoriasis	5.34e-05	0.000143	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—NFKBIA—psoriasis	5.11e-05	0.000137	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—IL6—psoriasis	4.89e-05	0.000131	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—TYK2—psoriasis	4.19e-05	0.000112	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—TP53—psoriasis	4.16e-05	0.000112	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—IL6—psoriasis	3.81e-05	0.000102	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—CXCL8—psoriasis	3.65e-05	9.78e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—JUN—psoriasis	3.39e-05	9.09e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—NFKB1—psoriasis	3.26e-05	8.75e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—VEGFA—psoriasis	2.96e-05	7.94e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—STAT3—psoriasis	2.93e-05	7.87e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—TP53—psoriasis	2.24e-05	6e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—IL6—psoriasis	2.05e-05	5.49e-05	CbGpPWpGaD
